Edinburgh Research Archive logo

Edinburgh Research Archive

University of Edinburgh homecrest
View Item 
  •   ERA Home
  • Edinburgh Medical School
  • Edinburgh Medical School thesis and dissertation collection
  • View Item
  •   ERA Home
  • Edinburgh Medical School
  • Edinburgh Medical School thesis and dissertation collection
  • View Item
  • Login
JavaScript is disabled for your browser. Some features of this site may not work without it.

Nicotinic acetylcholine receptors and their interaction with Aβ₁₋₄₂

View/Open
CrawfordN_2006redux.pdf (40.74Mb)
Date
2006
Author
Crawford, Nicola
Metadata
Show full item record
Abstract
 
 
Alzheimer's Disease (AD) is a progressive, age-related disease that is positively characterised by the post-mortem presence of neurofibrillary tangles and amyloid plaques. At present ~ 5 % of those aged over 65 years are diagnosed with AD, with this figure increasing to ~ 20 % for those aged over 75 years. It is nearly 100 years since AD was first characterised in 1907, however the exact cause has yet to be determined with the cholinergic and beta-amyloid (Ap) hypotheses remaining central to the aetiology. The cholingergic hypothesis suggests that loss of the cholinergic pathways precedes that of any other neurotransmitter making it a primary target in AD and predating the amyloid hypothesis which itself postulates that deposition of Ap is primarily responsible for the neurodegeneration in AD. Until recently, these two hypotheses have been almost exclusively studied in separation. However, recent studies suggest that the two major CNS cholinergic nicotinic acetylcholine receptor subtypes a4p2 and a7 may interact directly with Ap and therefore, a multidisciplinary approach has been used to evaluate the reported interaction.
 
Radioligand binding was used to characterise the α₄ß₂ nAChR ([³H]-epibatidine and [³H]-cytisine) and α₇ nAChR ([³H]-methyllycaconitine ([³H]-MLA) and [³H]- αBungarotoxin ([³H]-αBgTx)) in rat and mouse brain tissue and in SH-EP1 cell lines overexpressing human forms of the α₄ß₂ or α₇ nAChRs. No species difference in ligand affinities were observed for the α₄ß₂ nAChR. In contrast, nicotinic agonists exhibited significantly higher affinity (~100 fold) for human α₇ nAChRs compared to their rat counterparts with no change in antagonist affinity. Interestingly, evaluation of [³H]-MLA and [³H]-aBgTx binding indicated the latter ligand bound to a restricted number of sites on the α₇ nAChR. Furthermore, neither human nor rat αß₁₋₄₂ inhibited [³H]-cytisine or [³H]- MLA binding to nAChRs. In parallel to behavioural studies, these binding assays were also employed to assess nAChR pharmacology in transgenic α₇ knockout mice. With no alteration in α₄ß₂ nAChR pharmacology, the deficit in sustained attention exhibited by these α₇-KO mice is probably due to loss of the α₇ nAChR.
 
Finally, a series of studies was performed to examine the functional interaction between αß₁₋₄₂ and nAChRs. (-)Nicotine evoked changes in calcium flux or membrane potential in SH-EPl-hα₄ß₂ cells were not inhibited by soluble or insoluble human αß₁₋₄₂. Even whole cell patch clamp analysis of single cells showed no direct interaction between the αß₁₋₄₂ nAChR and αß₁₋₄₂. The examination of the functional interaction between α₇ nAChRs and αß₁₋₄₂ using whole cell patch clamp or fluorescence based assays was compromised by a lack of consistent expression of functional human α₇ nAChRs in the SHEP1 cell line. In addition, neither human α₄ß₂ nor α₇ nAChRs co-immunoprecipitated with human αß₁₋₄₂.
 
In conclusion, using a systematic multidisciplinary approach incorporating functional and non-functional assays the following major observations were made (1) species differences in α₇ but not α₄ß₂ nAChR pharmacology, (2) the two α₇ nAChR antagonists MLA and αBgTx differ in their ability to bind the α₇ homopentamer, (3) removal of the α₇ nAChR does not alter a4p2 nAChR pharmacology in transgenic mice (4) neither soluble or insoluble αß₁₋₄₂ interacted in pharmacological, functional, or biochemical assays with the rodent or human α₄ß₂ or α₇ nAChRs.
 
URI
http://hdl.handle.net/1842/29079
Collections
  • Edinburgh Medical School thesis and dissertation collection

Library & University Collections HomeUniversity of Edinburgh Information Services Home
Privacy & Cookies | Takedown Policy | Accessibility | Contact
Privacy & Cookies
Takedown Policy
Accessibility
Contact
feed RSS Feeds

RSS Feed not available for this page

 

 

All of ERACommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsPublication TypeSponsorSupervisorsThis CollectionBy Issue DateAuthorsTitlesSubjectsPublication TypeSponsorSupervisors
LoginRegister

Library & University Collections HomeUniversity of Edinburgh Information Services Home
Privacy & Cookies | Takedown Policy | Accessibility | Contact
Privacy & Cookies
Takedown Policy
Accessibility
Contact
feed RSS Feeds

RSS Feed not available for this page